Pre- and post-stroke memantine administration attenuates neurological deficits, infarct size, and astrogliosis, with a concomitant increase in MAP2 protein in a rat stroke model

Experimental Neurology · Published 2026-07-30 · DOI 10.1016/j.expneurol.2026.115949

Authors (3)

Nestor I. Martínez-Torres, Jhonathan Cárdenas-Bedoya, Blanca Miriam Torres-Mendoza

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Martínez-Torres, N., Cárdenas-Bedoya, J., Torres-Mendoza, B. (2026). Pre- and post-stroke memantine administration attenuates neurological deficits, infarct size, and astrogliosis, with a concomitant increase in MAP2 protein in a rat stroke model. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2026.115949

Related articles